Navigation Links
EvolutionHealth.com Adds Air Cleansing Purifier to Their Must-Have Products for Health
Date:11/17/2008

ody, and this one of the most important things you can do when it comes to creating health and boosting your immune system."

For a limited time, EvolutionHealth.com is offering a free IQ Air Purifier (an $800 value) with the purchase of a luxury Infrared sauna. The benefits of infrared therapy are far reaching. From detoxification to passive cardiovascular conditioning, infrared sauna therapy will positively impact your health.

EvolutionHealth.com offers Self-Maintenance Tools that are based on Blue's research and experience over the last 24+ years. He has determined that these rejuvenating tools are the foundation of optimal health and fitness, this foundation being comprised of: Functional Flexibility and Functional Strength, Nutrition, Detoxification and Cleansing, and Inversion.

EvolutionHealth.com was founded by Blue Dunn, creator of Flextasy! The Functional Flexibility System. The products he has made available to the public are ones he regularly uses and based on 20+years of search, research, and experiment. Blue Dunn considers these products to be the crème de la crème and his collection of favorites, which have changed his life, and the lives of his clients for the positive.

EvolutionHealth.com offers an extensive line of health products, including infrared saunas, Inversion table equipment, Rebounder equipment, air purifiers, and nutritional supplements.

###

Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. VIDEO from Medialink and Revolution Health: RevolutionHealth.com Launches Resolutions 2.0
2. Consumer Reports Finds Filter-Based Air Purifiers are Better Choice for Consumers
3. One-fourth of HIV patients believe their doctors stigmatize them
4. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
5. Teens need to see their doctors more often
6. Can brain-injured, partially-blind stroke patients regain some of their lost vision?
7. Scientists explain how insulin secreting cells maintain their glucose sensitivity
8. When Should Children Wash Their Hands?
9. UCLA/RAND study shows that many children of HIV-positive parents are not in their custody
10. National Association for Home Care & Hospice (NAHC) Members Take Their Case to Capitol Hill
11. Nurses describe dedication, frustration associated with their jobs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ancer patients who have a prostate-specific antige...years after external beam radiation therapy (EBRT)...ancer-related death, according to a study in the D...diation Oncology*Biology*Physics, the official jou...y (ASTRO)., PSA levels in a prostate cancer pati...
(Date:12/2/2009)... National Pen ( www.pens.com ), a wor...unced today it is giving away 10,000 free business...ember 2, 2009 -- National Pen ( www.pens.com ), a ...nounced today it is giving away 10,000 free busine...o promote business that no other company in the in...
(Date:12/2/2009)... National Race Series to increase awa...r families on the importance of early detection ,...er 2, 2009 -- Men, women, families, friends and ne...invited to participate in the Rudolph Ramble 5K. ...ACE Race Series , which was launched by the Prost...
(Date:12/2/2009)...CHICAGO, Dec. 2 The Ame...Board of Directors today announced Alan F. Dowling...000-member health information management (HIM) lea...xperience includes academia, systems management, s...ot-for-profit executive leadership. He is schedul...
(Date:12/2/2009)... $1 Million - 4 State Campaign Features Small Bus... Businesses and Would Kill Jobs ,, WASHINGTON,...e House jobs summit scheduled for Thursday, Keepin...te for Liberty, today announced a new $1 million 4...fects of the current health care legislation on sm...
Breaking Medicine News(10 mins):Health News:PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients 2Health News:National Pen Giving Away 10,000 Business Card Pens 2Health News:PACE Race Returns with Denver's Rudolph Ramble 2Health News:PACE Race Returns with Denver's Rudolph Ramble 3Health News:PACE Race Returns with Denver's Rudolph Ramble 4Health News:Dr. Alan F. Dowling Named AHIMA's Next Chief Executive Officer 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 3Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 4
..., a spinal,technology development company whose fo...d today the national launch of the STATURE Vertebr...adiolucent MIS compatible spacer,system designed t...rk and clinical evaluation, it is,rewarding to see...
... . , , Montreal, May 22, 2008 Expectant mothers...their first trimester, according to a new study fr...tal published in the May edition of the British Jo...stigate the impact of antidepressant use during th...
....,(NYSE: PRE ) today announced that it intends to...iary PartnerRe Finance A LLC, $250 million of,10-y...s currently effective,shelf registration statement...ng to,repay all of the $220 million of third-party...
...ach of Novel Technology, N. BILLERICA, Mass., May...urement of cellular bioenergetics, announced today...ive supplier of Seahorse,XF instruments and consum...m by Takeda,Pharmaceutical Company and with its in...
...p,Inc. (Nasdaq: NYER ) reported results for the t... three months ended March 31, 2008 increased $1.55...lion as reported for the,same period last year. Ne...riod ended March 31, 2007. The net loss reflects,c...
... and BREASTCANCER.ORG founder, in,open letter to C...ion ACT, H.R. 758, ...ectomies is an unconscionable practice that can en...tcancer.org, in,an open letter to Congress today a...
Other Medicine News:Health News:Atlas Spine Launches Stature(TM) Vertebral Body Replacement System 2Health News:PartnerRe Ltd. to Issue $250 million in 6.875% Senior Notes 2Health News:PartnerRe Ltd. to Issue $250 million in 6.875% Senior Notes 3Health News:Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market 2Health News:Nyer Medical Group, Inc. Reports Revenues of $18.9 Million With Net Loss of $.16 Per Share for 3rd Quarter of Fiscal Year 2008 2Health News:Nyer Medical Group, Inc. Reports Revenues of $18.9 Million With Net Loss of $.16 Per Share for 3rd Quarter of Fiscal Year 2008 3Health News:Drive-Through Mastectomies Threaten Patients' Lives 2
(Date:12/2/2009)..., , CENTENNIAL, Colo., Dec. 2 /PRNewswire...rofit providers of skin, bone and soft tissue allo...d,s largest processor of live cellular bone growth... truly iconic symbol of hope as a float rider aboa...2010 Tournament of Roses Parade®. Manuel Sal...
(Date:12/2/2009)..., , DUBLIN, Ohio, Dec. 2 /PRNewswire-First...ie Cox will serve on the company,s board of direct...cently served as executive vice president and pres... Corp. She completed her tenure with the company a...,, Prior to her term at Schering-Plough, Cox se...
(Date:12/2/2009)..., , ROCKVILLE, Md., Dec. 2 /PRNewswire-Fi...eported favorable initial results from the first s...ing the safety and immunogenicity of the company,s...uenza vaccine. Novavax is conducting this study i... to support registration of the vaccine in Mexico ...
Breaking Medicine Technology:AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 2AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 3Cardinal Health Names Carrie Cox to Board of Directors 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4Trubion Announces Acceptance of Two Presentations on Its TRU 016 Product Candidate at the 2009 ASH Annual Meeting 6186 1Trubion Announces Acceptance of Two Presentations on Its TRU 016 Product Candidate at the 2009 ASH Annual Meeting 6186 2Trubion Announces Acceptance of Two Presentations on Its TRU 016 Product Candidate at the 2009 ASH Annual Meeting 6186 3Trubion Announces Acceptance of Two Presentations on Its TRU 016 Product Candidate at the 2009 ASH Annual Meeting 6186 4Endo Pharmaceuticals and LecTec Settle Patent Dispute 6182 1Endo Pharmaceuticals and LecTec Settle Patent Dispute 6182 2Endo Pharmaceuticals and LecTec Settle Patent Dispute 6182 3Endo Pharmaceuticals and LecTec Settle Patent Dispute 6182 4Boys Team Sports May Encourage Bad Behavior 61189 1Boys Team Sports May Encourage Bad Behavior 61189 2Boys Team Sports May Encourage Bad Behavior 61189 3
...onference Call on Monday, April 14, at 8:30 a.m. E...m.com , CARLSBAD, Calif., April 14 Isis,Pharmace...l results from its,ongoing Phase 2 open-label exte...amilial hypercholesterolemia (FH). In FH patients ...e safety profile of the drug,continues to be encou...
...3 Researchers from the,Barbara Ann Karmanos Cance...owing that adding curcumin or resveratrol to conve...ing the growth of chemo-resistant colon cancer,cel...merican Association,for Cancer Research (AACR) Ann...om.com/cgi-bin/prnh/20071106/KARMANOSCANCERINSTITU...
Other Medicine Technology:Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 2Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 3Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 4Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 5Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 6Karmanos Researchers Find Non-Toxic Agents Added to Conventional Chemotherapy Decrease Survival of Colon Cancer Cells 2
TSH Receptor (TSHR) Autoantibody - RIA
TSH Receptor (TSHR) Autoantibody - ELISA
TSH Receptor (TSHR) Autoantibody Coated-Tube (CT)
Thyroid Peroxidase (TPO) Autoantibody - RIA
Medicine Products: